Skip to main content

Articles

  • KETAMINE: A MAGIC REMEDY

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Kshitij Nuwal, Shailja Jain, Kamal S. Rathore
    B.N.I.P.S., UDAIPUR

    kshitij.nawal10@gmail.com

    ABSTRACT:
    The largest, longest study conducted on depression treatments, called the STAR*D trial, found that after people tried four antidepressants over the course of five years, about 70% of them were free of depressive symptoms. That’s a lot of trial and error to end at a place where 30% of patients don’t experience remission at all. The STAR*D trial ended in 2014, and despite a clear hole in the market–and a clear patient need–a golden age of new depression treatments still hasn’t arrived. The anesthetic ketamine could offer hope for people who don't have other depression treatment options. The most recent research on ketamine, as well as a statement from experts on its use published in April 2017, finds the drug works quickly, makes dramatic improvements in mood, and can work on people who haven’t gotten better with other depression treatments.

  • NOVEL DRUG DELIVERY SYSTEMS IN MANAGEMENT OF CARDIOVASCULAR DISEASES

    { DOWNLOAD AS PDF }

    SHYAMOSHREE BASUABOUT AUTHOR
    SHYAMOSHREE BASU
    Advanced Cardiac Center,
    B.R. Singh Hospital & Centre for Medical Education & Research
    Sealdah, Kolkata – 700014 West Bengal

    shyamoshree@gmail.com

    ABSTRACT
    Cardiovascular (CV) diseases like atherosclerosis, angina pectoris, acute myocardial infarction, are a major cause of mortality in the whole world owing to the present day hectic lifestyle. In this review we will concentrate on the various novel drug delivery systems (DDS) like transdermal DDS, micelles, liposomes, nanoparticles (NPs), dendrimers, drug eluting stents (DES) and drug eluting balloons (DEB) that are being used over the years and in present day for the treatment of these diseases.

  • CANCER CURE: HANDLE GENTLY (NEW HOPES FOR PATIENTS AND RESPONSIBILITIES OF SCIENTISTS)

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Dr. Vishwas
    *, B. Chavan
    Aditya Jyot Eye Hospital and Foundation
    *vishwaschavan2003@yahoo.co.in

    ABSTRACT
    Cancer is one of the leading causes of morbidity and mortality worldwide. Many patients succumbed to the disease despite best efforts from medical and surgical oncologists. This is because of several challenges like treatment resistance, genetic heterogeneity of tumor cells and high cost of new therapies. It is clear from the recent research that to overcome cancer, a gentler approach is necessary. This approach include controlling inflammatory processes, discovering compounds which can offer minimum resistance from cancer cells, targeting therapy where it is actually needed and increase strength of the patient’s body by non-drug ways like exercise and modulating gut microflora. Scientists can help the patients more directly by devising more clinical level studies and publishing results as much as possible, even negative ones (like failure of a novel drug to treat cancer), to avoid loss of precious time and money. A coordinated effort from clinicians, patients and scientists planning studies at clinical level and publication of data, even negative ones can help defeat cancer, even at advanced metastatic stage IV stage.

  • ORAL DRUG DELIVERY SYSTEM CHALLANGES TO PEDIATRICS AND CURRENT APPROACHES

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Poonam R. Ithape1*, Priyanka D. Ghadage1, Jayant K.Gadhve1,Akash S.Mali
    Gourishankar Institute of Pharmaceutical Education and Research,
    Limb, Satara, Maharashtra
    *poonamithape6996@gmail.com

    ABSTRACT
    The focus of present study is to exist a novel methods for pediatric oral drug delivery.To overcome the problems associated with drug administration,toxicity and taste preference the drug designed in such way that it best suits to child age,required treatment,size and physiological condition.Pediatrics differs from adult in many aspects of pharmacotherapy. Palatability is the biggest challenge while designing the pediatric formulation. As the vast no of limitation present in solid formulation there is wide scope in novel research in designing the pediatrics drug delivery system. Novel approaches in oral drug delivery system is somewhat satisfy the challenges but not the give proper solution. To overcome these problems the novel innovativeresearches is going on. The formulation should be designed in such a way that is easy to administer for pediatrics,having dose flexibility and better palatability of drug formulation.

  • STEM CELL THERAPY FOR PARKINSON’S DISEASE: A REVIEW

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Vipul Gandhi*, Sushil Burle, Satish Kosalge
    Hi-Tech College of Pharmacy Chandrapur
    Padoli Phata,  Nagpur Highway, Morwa, Chandrapur-442406.
    *vipul96gandhi@gmail.com

    ABSTRACT
    Some of the problems with Un productive relaxing treatments and insufficient repair aptitude in the central nervous system are most troubling problems for few neurological diseases. Providentially, the development of clinically relevant populations of stem cells has provided an opportunity to overcome the failure of endogenous repair systems and substitute new cells into the injured brain. However, there are still several existing difficulties in interpreting into clinical application. In this review, we mainly focus on the stem cell based therapies for Parkinson’s disease and discuss the possible advantages and drawbacks. We hope this review may provide suggestions for viable policies to overcome the current technical and biological issues relatedto the application of stem cells in Parkinson’s disease (Fu et al., 2015).

  • APICOPLAST: A BRILLIANT FOCUS FOR ANTIMALARIAL DRUG DEVELOPMENT

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Souvik Mukherjee*1, Deepronil Roy2 and Suman Das3
    1Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, Bathinda, Punjab, India
    2Department of Animal Sciences, Central University of Punjab, Bathinda, Punjab, India  3Department of Human Genetics & Molecular Medicine, Central University of Punjab, Bathinda, Punjab, India
    mukherjees388@gmail.com

    ABSTRACT
    Malaria is a lifestyle-threatening tropical disorder, due to the intracellular parasite Plasmodium falciparum. The sector health employer counts malaria as one of the pinnacle ten reasons of worldwide demise. The unavailability of a successful malaria vaccine and the ever-increasing times of drug resistance in the malaria parasite call for the invention of new targets inside P. falciparum for the development of next generation antimalarial drug. Fortuitously, all apicomplexan parasites, along with P. falciparum harbor a relict, non-photosynthetic plastid referred to as the apicoplast. The apicoplast is a semi-self-sustaining organelle within P. falciparum, containing a 35 kb circular genome. Notwithstanding a genome of its own, majority of the apicoplast proteins are encoded by means of the parasite nucleus and imported into the apicoplast. The organelle has been proven to be vital to P. falciparum survival and the loss the apicoplast manifests as a ‘not on time loss of life’ response in the parasite. The apicoplast has advanced out of cyanobacteria in a complicated, two step endosymbiotic event. As a result, the architecture and the gene expression machinery of the apicoplast is pretty bacteria-like and is at risk of a wide variety of antibiotics consisting of fosmidomycin, tetracycline, azithromycin, clindamycin and triclosan. The biosynthetic pathways for isoprenoids, fatty acids and heme function within the malaria apicoplast, making the organelle a top notch goal for drug development. This review specializes in the evolution, biology and the essentiality of the apicoplast inside the malaria parasite and discusses a number of the current achievements toward the layout and discovery of apicoplast focused antimalarial drug.

  • ISATIN SCHIFF BASE -AN OVERVIEW

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    D.Visagaperumal*, Justin Ebuka Ezekwem, Hemaprasad Munji, Vineeth Chandy
    Department of Pharmaceutical Chemistry,
    T. John College of Pharmacy, Bangalore, Karnataka, India
    *vishak_dr@yahoo.co.in

    ABSTRACT
    The review article is focused on studies of Isatin-based Schciff Bases and their biological and pharmacological activities. Isatin-based Schiff base are generally synthesized by condensation of the keto group of Isatin with different aromatic primary amines carrying imine or azomethine (–C=N–) functional group. Isatin Schciff Base possesses numerous biological properties like antitumor, antimicrobial, anti-inflammatory, anticonvulsant, antiviral, anti HIV, antioxidant, CNS depressant activities

    [adsense:336x280:8701650588]

  • REVIEW ON ISCHEMIC HEART DISEASES AND ITS MEDICATION

    ABOUT AUTHORS
    Salman S. Dhankwala*, Ajinkya N. Gavsane, Prithvirj M. Ghuli, Sagar A. Jadhav
    Department of Pharmaceutical Chemistry,
    Appasaheb Birnale College of Pharmacy,
    Sangli, Maharashtra, India
    *salman.2.dhankwala@gmail.com

    { DOWNLOAD AS PDF }

    ABSTRACT
    Ischemic heart diseases are a major public health problem, it includes disorders of the heart and blood vessel. Ischemia is a condition in which the blood flow (and thus oxygen) is restricted or reduced in a part of the body.Cardiac ischemia is the name for decreased blood flow and oxygen to the heart muscle It's the term given to heart problems caused by narrowed heart arteries. When arteries are narrowed, less blood and oxygen reaches the heart muscle. This is also called coronary artery disease and coronary heart disease. This can ultimately lead to attack. Ischemia often causes chest pain or discomfort known as angina pectoris. Disease is diagnosed according to medical parameters; following diagnosis of the disease the treatment is started. The treatment is includes in medicines of Heart diseases and is as well as lifestyle.

  • HEALTH RISK ASSESSMENT TO ZINC IN DRINKING WATER OF RURAL RESIDENTS LIVING IN BHUSAWAL CITY, MAHARASHTRA (INDIA)

    { DOWNLOAD AS PDF }

    PhotoABOUT AUTHORS
    Sanjay A. Nagdev*1, Mayur R. Bhurat1 and Krishna R. Gupta2
    1 K.Y.D.S.C.T’s College of Pharmacy, Sakegaon-Bhusawal, Maharashtra
    2 Smt. Kishoritai Bhoyar college of Pharmacy, Kamptee, Maharashtra
    *snsanjurocks@gmail.com

    ABSTARCT
    The Present study was designed for the estimation of essential trace element Zinc in drinking water from natural sources like well, bore-well and river of Bhusawal (Maharashtra) (21.0455° N, 75.8011° E).Samples were evaluated as per Bureau of Indian standards 10500 for Zinc, Concentration of Zinc in water samples of River, well and Bore well was found within the safe limits of World Health Organization guidelines for zinc and also study finding suggest that bore well is the better and rich source of Zinc as compared to Well and river and population residing in the region and consuming water from bore well would be less prone to Zinc deficiency as compared to Population consuming water from other sources like well and river.

  • VISUALIZING CHALLENGES OF GST ON DIFFERENT CORNERS OF PHARMACEUTICAL INDUSTRY

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    ABDUL KHALID QUADRI*, MD. BARKATH ALI SHAMS
    Department of Pharmacy practice, Deccan School of Pharmacy, Hyderabad-500001, Telangana, India
    *a.k.quadri4all@gmail.com

    ABSTRACT
    The Indian pharmaceutical industry is amongst the largest producer of pharmaceutical products in the world (by volume). The pharmaceutical sector is witnessing high growth rate over the past 8-10 years, it has been burdened with diminishing margins. The Indian pharmaceutical industry is facing pressures of increasing span control on account of changing regulations. GST which embodies the principle of one nation, one tax, one market is aimed at unifying the country’s INRs 124.9 trillion economy and 1.3 billion people into a common market. For corporates, the elimination of multiple taxes will improve the ease of doing business. And for consumers the biggest advantage would be in terms of reduction in overall tax burden on goods. In other words GST would make doing business in the country tax-neutral, irrespective of the choice of place of doing business, the important roll-out of GST is to provide a method for companies to simplify their operations, and achieve better efficiencies enabling them to serve customers better. It is also expected that supply chain and other operational planning opportunities and efficiencies may be available, depending on a company’s facts. However, in short–term/transitional phase, pharmaceutical industry, are likely to face a number of challenges, including possibly negative financial impacts, the need to assess existing supply chain structures, the need for reconfiguration of  IT systems and more. The warehouse cost can be reduced and rationalized the supply cahin, it has a negative effect on ayurvedic products as its rate will increase from the present rate because of increase in tax slab. GST is expected to fetch a good revenue through increase in medical tourism, GST is surely going to benefit the pharmaceutical industries. It will create a level playing field for generic drug makers, boost medical tourism and simplify the tax structure.

Subscribe to Articles